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Abstract
AIM: To investigate the safety profile of acquiring 
additional intestinal biopsies for research purposes in 
children undergoing a medically indicated colonoscopy. 
METHODS: A retrospective review of 122 pediatric 
patients who underwent colonoscopy over a 9 mo time 
period was completed. 38/122 participants consented 
to a research study in which 4 additional biopsies were 
obtained, in addition to routine biopsies. The outcomes 
after colonoscopy were measured in the research 
participants, and compared to 84 control participants who 
did not consent for the study. Groups were compared 
with regard to number of biopsies obtained, underlying 
diagnosis, and both serious and minor adverse outcomes. 
Data was collected including: age, gender, race, indication, 
diagnosis, number of biopsies obtained per case and 
post procedure adverse events. Medical records were 
reviewed and a questionnaire was completed by each of 
the ten gastroenterologists who performed procedures 
during the study. Physicians were asked about individual 
patient outcomes to ensure that all adverse events, such 
as perforation, excessive bleeding, infection, and minor 
gastrointestinal outcomes, were captured and included.
RESULTS: The research group had more biopsies 
obtained (mean = 13.58 ± 4.21) compared to controls 
(mean = 9.33 ± 4.40), P  ≤ 0.0001, however there 
was no difference in adverse events. Serious outcomes, 
defined as perforation, bleeding and infection, did not 
occur, in either group. As such, the relationship between 
serious adverse events and number of biopsies obtained 
was not determined. Minor gastrointestinal outcomes, 
such as abdominal pain, diarrhea or vomiting, were 
reported in 21 patients (8 research participants and 13 
control participants) however the incidence of minor 
gastrointestinal outcomes between the two groups did 
not vary significantly, P = 0.45. Additionally, the mean 
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Retrospective Study
number of biopsies obtained in patients who had a 
minor outcome (mean = 12.1 ± 0.77), compared to 
those with no adverse outcome (mean = 10.34 ± 0.5), 
revealed no statistical difference between the groups 
(P  = 0.12), suggesting that number of biopsies is not 
associated with incidence of minor adverse events.
CONCLUSION: Patients participating in research requir-
ing acquisition of additional biopsies for research purposes 
alone, are not at an increased risk of adverse outcomes.  
Key words: Pediatric colonoscopy; Outcomes; Research; 
Safety; Intestinal biopsy
© The Author(s) 2015. Published by Baishideng Publishing 
Group Inc. All rights reserved.
Core tip: Acquiring biopsies for research purposes during 
a colonoscopy may facilitate translational research in the 
field of gastroenterology. However, the safety profile of 
acquiring research biopsies has not been established. 
Our study is the first to conclude that acquiring additional 
biopsies for research during a colonoscopy does not pose 
additional risk to the pediatric patient. This manuscript 
may serve as a reference to researchers applying for IRB 
approval in biological specimen studies. Additionally, our 
study is additive to the body of literature on outcomes 
after pediatric colonoscopy, in that minor gastrointestinal 
symptoms were the only reported adverse event after 
colonoscopy.
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INTRODUCTION
Colonoscopy with biopsies is a common procedure 
in children for the evaluation and diagnosis of gas­
trointestinal disease. Serious complications, such 
as perforation and bleeding are routinely discussed 
during the consent process, however, these events 
are rare[1­3]. Several adult studies have sought to 
measure the incidence of adverse outcomes during 
routine procedures[2,4,5], and this data has largely 
been applied to the pediatric population[6]. In adults, 
colorectal perforation is presumed to occur in 0.09% 
of the general population[7,8], while it remains unclear 
as to whether patients with pre-existing inflammatory 
bowel disease (IBD) are at an increased risk for serious 
outcomes, such as perforation[7,9,10]. The incidence of 
bleeding after colonoscopy is thought to occur infre­
quently during routine procedures[8].
There is limited data on serious adverse events in 
children, such as bleeding. Although one study found 
that 38.6% (34/86) of all reported complications were 
related to gastrointestinal bleeding, bleeding was 
not defined[3].  Other pediatric studies did not include 
bleeding in their outcome analysis[6]. Infection, similarly 
regarded as a serious and uncommon outcome after 
colonoscopy, has not been widely studied in pediatrics[11]. 
Likewise, minor post­procedure gastrointestinal symp­
toms, such as bloating and abdominal pain, are not well 
described in the pediatric literature[12].
The current pediatric studies are limited in number 
and do not quantify the number of routine biopsies 
obtained per procedure which may be a risk factor for 
adverse events. Additionally, these studies have not 
addressed whether obtaining additional biopsies solely 
for research purposes imposes additional risk to the 
patient. To our knowledge, this issue has not been 
addressed in the pediatric or adult literature. It is critical 
to establish the safety profile of collecting additional 
biopsies for research during routine procedures, so that 
investigators seeking institutional review board (IRB) 
approval are able to proceed with important research 
questions. The absence of this risk assessment may 
explain why studies involving the collection of pediatric 
biological specimens are difficult to pursue. Such IRB 
protocols pose a challenge to both author and reviewer, 
in that the lack of prior safety data serves as an obstacle 
for IRB approval. To address this gap, we performed a 
retrospective review for all children undergoing routine 
medically indicated colonoscopies and measured 
adverse events. Thirty­one percent of the participants 
had previously consented for a research study involving 
the acquisition of four additional intestinal biopsies 
designated for research purposes. By comparing adverse 
events in the research study participants to patients 
who did not consent, the controls, we established that 
acquiring additional biopsies for research alone is safe.
MATERIALS AND METHODS
We performed a retrospective review of all pediatric 
patients undergoing a medically indicated routine 
colonoscopy from June 5, 2013­March 5, 2014. Anesth­
esia was provided by pediatric anesthesiologists. 
Patients who had previously provided written and 
oral consent for a biological specimens study were 
identified (n = 38); these participants consented to have 
four additional intestinal biopsies taken for research 
purposes alone. This research­consented cohort was 
then compared to non­study participants (n = 84), who 
had only routine biopsies obtained during the procedure. 
Data was collected including: age, gender, race, 
indication, diagnosis, number of biopsies obtained per 
case and post procedure adverse events. Post­proce­
dure adverse events were defined as events occurring 
within one week of the procedure. Medical records were 
reviewed for patient phone calls, general practitioner 
and gastroenterology clinic appointments, emergency 
department visits and hospital admissions within one 
week post­procedure. For those patients who were 
admitted to the hospital prior to their colonoscopy, the 
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inpatient record was reviewed.  
We administered a questionnaire to the ten gastroen­
terologists who performed procedures during the afore­
mentioned time period regarding individual patient 
outcomes to ensure that all adverse events, such as 
perforation, excessive bleeding, infection, and minor 
gastrointestinal outcomes, were captured and included. 
This study was approved by the Office of the Human 
Research Protection Program, Institutional Review 
Board at Albert Einstein College of Medicine, Bronx, NY.  
Statistical analysis
Differences in participant demographics between groups 
were compared using analysis of variance or t tests for 
continuous variables and χ 2 or Fisher’s exact tests for 
categorical variables. All analyses were performed using 
GraphPad Prism version 6 (San Diego, CA). All tests for 
significance were two­sided, and a value of P < 0.05 
was considered significant. 
RESULTS
A total of 122 colonoscopies were performed during the 
study period: 38 patients consented to have additional 
biopsies obtained for research during the medically 
indicated procedure, compared to 84 non­research 
related cases. One thousand two hundred and ninety 
biopsies were obtained, including 136 intestinal biopsies 
for research alone. The average number of biopsies 
obtained per case was significantly higher in the research 
cohort, 13.6 compared to 9.3 in the control group, (P < 
0.0001) (Table 1). Participant demographics are detailed 
in Table 1. Of note, statistical differences in race and 
age were observed in the research compared to the 
control groups, P = 0.04 and P = 0.05, respectively. One 
patient (2.6%), age 0­5, participated in the research 
study, compared to 16 (19%) who underwent routine 
colonoscopy alone (P = 0.05). No statistical difference 
in gender distribution was observed when comparing 
research to control participants.
The research cohort consisted of 38 patients, 17/38 
(44.7%) of whom had IBD, compared to 21/84 (25%) 
of the patients in the control group (P = 0.03) (Table 
1). IBD diagnosis type, such as Crohn’s disease (CD) or 
ulcerative colitis (UC), did not vary significantly between 
the two groups, P = 0.23. 
There were no cases of perforation, infection or 
hemorrhage in the research or the control group.  Given 
that no serious outcomes occurred in our cohort, the 
relationship between number of biopsies and serious 
adverse events was not measured. Minor gastroin­
testinal outcomes, however, did occur in 8/38 research 
participants, and 13/84 control participants (Table 2). 
The incidence of minor gastrointestinal outcomes was 
not statistically different when comparing the research 
and control groups, P = 0.45, although the research 
group had significantly more biopsies obtained per 
procedure, P < 0.0001. Additionally, the mean number 
of biopsies obtained in patients who had a minor 
outcome (mean = 12.1 ± 0.77), compared to those 
with no adverse outcome (mean = 10.34 ± 0.5), 
revealed no statistical difference between the groups 
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Research group 
(n  = 38)
Control group
(n  = 84)
P  value1
  Sex
     Male, n (%)  20 (52.6)   48 (57.1) 0.64
     Female, n (%)  18 (47.4)    36 (42.9)
  Age in years, n (%)
     0-5  1 (2.6)   16 (19.0) 0.05
     6-12  10 (26.3)   19 (22.6)
     13-21   27 (71.1)   49 (58.3)
  Race
     White, n (%)    5 (13.2) 26 (31) 0.04
     Non-white, n (%)  33 (86.8) 58 (69)
  Diagnosis
     IBD2, n (%)  17 (44.7) 21 (25) 0.03
     Normal 
     histology, n (%)
 21 (55.3) 63 (75)
  IBD diagnosis
     CD3, n (%)  11 (28.9)   10 (11.9) 0.23
     UC4, n (%)    5 (13.2)          11 (13)
     IC5, n (%)  1 (2.6)            0
  History of IBD
    Yes                  8          12 0.54
    No                  9            9
Table 1  Participant demographics
1All P values calculated to significance level of 0.05, 2Inflammatory Bowel 
Disease, 3Crohn’s disease, 4Ulcerative colitis, 5Indeterminate colitis.
Research group
(n  = 38)
Control group
(n  = 84)
P  value1
  Gastrointestinal symptom after
  Procedure, n (%)
     Yes   8 (21.1) 13 (15.5) 0.45
      No 30 (78.9)  71 (84.5)
  Mechanism of reporting 
      Phone call           6         6 0.14
      PGI2 clinic visit           0         1
      ED visit           2         1
      Inpatient           0         5
  Management
     Outpatient           5         6 0.81
     Admission to 
     hospital
          1         1
     Referral to ED           2         1
     Continued admission           0         5
  Gastrointestinal symptom3 (%)
    Abdominal pain only 2 (5.3) 4 (4.8) 0.82
    Abdominal pain 
     + diarrhea and/or 
     vomiting 
3 (7.9) 5 (6.0)
  Rectal bleeding 3 (7.9) 2 (2.4)
     Other 2 (5.3) 3 (3.6)
  Number of Biopsies
     Mean ± SD4 13.6 ± 4.2  9.3 ± 4.4  < 0.0001
Table 2  Minor gastrointestinal outcomes
1All P values calculated to a significance level of 0.05, 2pediatric gastroen-
terology, 3In research group, 1 patient with both abdominal pain and 
rectal bleeding, 1 with both rectal bleeding and constipation and in control 
group, 1 patient with rectal bleeding and diarrhea; 4standard deviation.
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which refutes prior findings[10]. A larger percentage of 
IBD patients (8/38, 21%) sustained minor adverse 
outcomes compared to non­IBD patients (13/84, 
15.5%), however this difference was not found to be 
statistically significant. Our findings support a prior 
study by Tam et al[9] that evaluated pain indices in 
children with IBD, pre and post procedure, and found 
that patients with functional bowel disease report more 
pain, compared to children with IBD[9].
Interestingly, our research­consented cohort con­
sisted of a larger percentage of IBD patients, 44.7% 
compared to 23.8% in the control group. From this, 
we may conclude that parental concern is greater in 
children more likely to have IBD, which may explain a 
greater willingness to participate in studies or to benefit 
from research. Alternatively, selection bias may impact 
the recruitment of children most likely to have IBD. In 
this study, however, all children undergoing colonoscopy 
during the aforementioned time period were asked to 
participate.
Given that serious adverse events did not occur 
in our cohort, we were unable to correlate number of 
biopsies obtained with incidence of serious adverse 
events. However, we did observe that of the patients 
who reported minor gastrointestinal outcomes, most 
(71.4%) reported the same symptom with which they 
presented for colonoscopy. Therefore, minor gastroin­
testinal events occurring after a procedure may be 
secondary to the primary gastrointestinal complaint, 
rather than the procedure. In regard to the consent 
process and clinical practice, clinicians may reassure 
parents that minor symptoms after a procedure are 
most commonly related to underlying symptoms on 
presentation, and not to the colonoscopy itself.
There are few studies in the current pediatric 
literature that discuss minor adverse outcomes after 
colonoscopy. Our study found that 17.2% of our popu­
lation reported minor symptoms after colonoscopy, 
which is consistent with prior data, for example, 
Steiner et al[12] found that post­procedure symptoms 
occur in 14%­17% of patients; sore throat, diarrhea 
and excessive gas occurred in 6% of patients, while 
abdominal pain occurred in 3%[12]. In our study 1.6% 
of participants were admitted post procedure for 
observation, while Steiner et al. admitted 1.1% patients, 
suggesting that the general concern level regarding 
minor symptoms is low. Of the 17 patients who reported 
symptoms, 1 was under the age of 5, suggesting 
either that minor symptoms are more common in older 
children, or that underreporting is at play in younger age 
groups. On a similar note, only 1 patient between the 
ages 0­5 participated in the research study, compared 
to 16 children in the control group under the age of 5, 
suggesting that parents of very young children are less 
likely to consent for studies requiring the collection of 
biological specimens. In one study, children 0­5 years of 
age were the most likely group to have a complication, 
P ≤ 0.001[3]; this supports the notion that very young 
(P = 0.12), suggesting that number of biopsies is not 
associated with incidence of minor adverse events. 
When comparing mechanism of reporting and mana­
gement of adverse minor events no statistical differences 
were noted when comparing research participants to 
controls. Likewise, gastrointestinal symptoms reported 
as minor events were similar between the two groups.
Overall, during this time period, 38 children with 
IBD underwent colonoscopy: 47.4% (18/38) of this 
group were newly diagnosed patients, 11 with CD, 6 
with UC, and 1 with indeterminate colitis, while 52.6% 
(20/38) had been previously diagnosed with IBD. Minor 
outcomes occurred in 21% (8/38) of patients with IBD. 
The incidence of minor adverse events in IBD versus 
non-IBD patients, did not vary significantly between the 
two groups, P = 0.45. 
The most common indication for colonoscopy was 
abdominal pain, occurring in 50% of patients, while 
diarrhea was the second most common indication (Table 
3). Weight loss, loss of appetite, fatigue, joint pain and 
rash occurred more often in the research group, P = 
0.01, P = 0.002, P = 0.001, P = 0.02, and P = 0.03, 
respectively. 
DISCUSSION
To our knowledge, no studies to date have evaluated 
the safety profile of taking additional intestinal biopsies 
for research purposes. Obtaining intestinal biopsies for 
research may facilitate investigations that will further 
our understanding of pediatric gastrointestinal illnesses. 
Our study shows that participation in research during 
a medically indicated colonoscopy does not place the 
patient at an increased risk for bleeding, perforation, 
infection, or minor gastrointestinal outcomes, which 
is in line with prior pediatric studies, as complications 
during routine colonoscopy are rare[3,6,7,9,11,13], and can 
be applied to studies involving biological specimens.
Adverse events after pediatric colonoscopy, particu­
larly in regard to IBD, have not been well studied, as 
subjects with pre­existing disease are often excluded 
from the cohort[6]. Our data suggests that patients with 
IBD are not at increased risk for perforation or bleeding, 
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  Indication (%) Research (n  = 38) Control (n  = 84) P  value1
  Abdominal pain              50              50        1
  Diarrhea 44.7 36.9  0.41
  Rectal bleeding 36.8 34.5        0.8
  Weight loss 44.7 20.2  0.01
  Loss of appetite 34.2 10.7    0.002
  Constipation 18.4 15.5  0.68
  Vomiting 15.8 14.3  0.83
  Fatigue 23.7     3.57    0.001
  Fever    7.89     3.57  0.31
  Joint pain 10.5     1.19  0.02
  Rash    5.26                0  0.03
Table 3  Indications for colonoscopy
1All P values calculated to a significance level of 0.05.
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The publication of this study may serve as a reference for researchers seeking 
IRB approval in biological specimen studies, and suggests the need for larger 
studies in the future. 
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patients may have an increased risk for complications 
after colonoscopy and that children over the age of 5 
may be more suitable candidates for research studies 
involving acquisition of additional biopsies. 
The limitations of our retrospective study include 
small sample size, limited duration of the study, and 
selection bias, as underlying gastrointestinal symptoms 
may have affected study outcome. Additional studies 
with larger groups of pediatric patients undergoing 
colonoscopy for medical reasons, while participating in 
research, are warranted in order to further attest that 
no additional risk is imposed to the patient. This will 
allow researchers to pursue questions that will enhance 
our current knowledge of chronic gastrointestinal pro­
blems in children, specifically IBD.
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